![](/images/graphics-bg.png)
Cost-Effectiveness of Real-World Administration of Concomitant Viscum album L. Therapy for the Treatment of Stage IV Pancreatic Cancer
المؤلفون المشاركون
Matthes, H.
Schad, Friedemann
Reinhold, Thomas
Thronicke, Anja
von Trott, Philipp
المصدر
Evidence-Based Complementary and Alternative Medicine
العدد
المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-8، 8ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2020-03-13
دولة النشر
مصر
عدد الصفحات
8
التخصصات الرئيسية
الملخص EN
Background.
For patients receiving add-on Viscum album L.
(VA) treatments for late-stage pancreatic cancer, an improved overall survival (OS) was observed.
Only limited information regarding cost-effectiveness (CE) for comparisons between standard of care and standard of care plus add-on VA in stage IV pancreatic cancer treatment is available.
The present study assessed the costs and cost-effectiveness of standard of care plus VA (V) compared to standard of care alone (C) for a hospital in Germany.
Methods.
An observational study was conducted using data from the Network Oncology clinical registry.
Patients included had stage IV pancreatic cancer at diagnosis and received C or V treatment in a certified German Cancer Center.
Cost and cost-effectiveness analyses (CEA) including the analysis of the incremental cost-effectiveness ratios (ICER) were performed from the hospital’s perspective based on routine data from the financial controlling department and observed data on OS.
The primary result of the analysis was tested for robustness in a bootstrap-based sensitivity analysis.
Results.
88 patients (C: n = 34; V: n = 54) were included, with a mean age 65.6 years and proportion of male patients 48.9%.
Adjusted hospital’s total mean costs for patients from the C and V groups were €10068.97 (over an adjusted mean OS time of 7.1 months) and €12267.94 (over an adjusted mean OS time of 10.6 months), respectively.
As to CEA analysis, a relevant total hospital’s savings of €260.81/month mean OS for V patients compared to C was calculated.
The costs per additional OS month gained (ICER) with the V treatment compared to C were €628.28.
Furthermore, a relevant hospital savings of €915.77 per mean hospital stay and additional costs of €75.09 per mean hospitalization day in the V group were observed compared to C.
Conclusion.
Based on this CEA analysis, from the hospital’s point of view, the costs per mean month of OS and per mean hospital stay were lower for patients under combinational standard of care plus VA compared to patients receiving standard of care alone for the treatment of stage IV pancreatic cancer.
Further prospective cost-effectiveness studies are mandatory to reevaluate our findings.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Thronicke, Anja& Reinhold, Thomas& von Trott, Philipp& Matthes, H.& Schad, Friedemann. 2020. Cost-Effectiveness of Real-World Administration of Concomitant Viscum album L. Therapy for the Treatment of Stage IV Pancreatic Cancer. Evidence-Based Complementary and Alternative Medicine،Vol. 2020, no. 2020, pp.1-8.
https://search.emarefa.net/detail/BIM-1155757
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Thronicke, Anja…[et al.]. Cost-Effectiveness of Real-World Administration of Concomitant Viscum album L. Therapy for the Treatment of Stage IV Pancreatic Cancer. Evidence-Based Complementary and Alternative Medicine No. 2020 (2020), pp.1-8.
https://search.emarefa.net/detail/BIM-1155757
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Thronicke, Anja& Reinhold, Thomas& von Trott, Philipp& Matthes, H.& Schad, Friedemann. Cost-Effectiveness of Real-World Administration of Concomitant Viscum album L. Therapy for the Treatment of Stage IV Pancreatic Cancer. Evidence-Based Complementary and Alternative Medicine. 2020. Vol. 2020, no. 2020, pp.1-8.
https://search.emarefa.net/detail/BIM-1155757
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1155757
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)